The Scottish Government has increased the Global Sum, guaranteed funding, drug tariff income mapping and guaranteed minimum income, in its community pharmacy funding arrangements for 2026/27.
The remuneration Global Sum will be reset for 2026/27 at £250.483 million, an increase of 3.5% on the previous year, while the non-Global Sum will roll forward at its current level set at £1.3 million.
The continued mapping of funding from Part 7 (generic) Drug Tariff as guaranteed income will increase by £10 million to £110 million for the financial year 2026/27.
Mapped guaranteed income is not subject to an annual uplift. The increase in mapped sum will be delivered by an equivalent reduction in drug tariff prices.
The current level of guaranteed minimum income has also been increased by £10 million to £130 million.
The delivery of the Guaranteed Minimum Income will be closely monitored on a monthly basis and action taken on a quarterly basis during the financial year via a cashflow protection mechanism, if required.
As per previous years, £2 million will be allocated to supporting the Post Registration Programme for Pharmacists (Scotland).
The deadline for applications has been extended to 30 September 2026.
Responding to the publication by Community Pharmacy Scotland of the 2026/27 Funding Settlement for community pharmacies in Scotland, Henry Gregg, Chief Executive of the National Pharmacy Association said: "This uplift is lower than many had hoped for, but we recognise and appreciate the work CPS has done in getting what they felt was the strongest deal available in the economic circumstances.
"The £10million increase to the Guaranteed Minimum Income will be welcomed by our members.
"We will do all we can to support our members, who now have much needed certainty about the financial envelope for the next 12 months and we are committed to helping ensure their businesses are resilient in tough financial times."
